Overview

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This non-interventional observational study is designed to gain data for Neupro® in restless legs syndrome (RLS) under real life conditions in line with the summary of product characteristics (SmPC) related to effectiveness, tolerability and switching practice from other dopaminergic drugs as well as titration schemes.
Details
Lead Sponsor:
UCB Pharma
Treatments:
N 0437
Rotigotine